Xermelo (telotristat)

pCPA File Number: 21118
Negotiation Status:
Negotiations were not pursued
Indication(s):
Carcinoid Syndrome
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals Canada, Inc.
CDA-AMC Project Number:
SR0580-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: